Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by StanleyTools1on Aug 03, 2012 11:19am
385 Views
Post# 20181257

These guys are priceless!

These guys are priceless!

Not only have they been overly generous rewarding each other with vital company cash, but then they consolidate the shares at 40cents, watch the stock crumble and then issue a huge pile of options at 16cents!!!

 

How much more can you guys take? Guys sell this dog and move on over to v.PTA, where they are doing the right things....

 

CALGARY, ALBERTA--(Marketwire - July 24, 2012) - Santa Maria Petroleum Inc. (formerly Quetzal Energy Ltd.) ("Santa Maria" or the "Company") (TSX VENTURE:SMQ) announces that it has granted stock options ("Options") to purchase an aggregate of 2,355,000 common shares of the Company at a price of
.16 per share to certain eligible participants. The 2,355,000 Options are exercisable for a period of five years from the date of grant and vest as to one-third on each of the first, second and third anniversaries of the date grant. As of the date hereof, the Company has granted Options to purchase an aggregate of 4,503,759 common shares of the Company.

Bullboard Posts